Celldex Therapeutics buy Citigroup Inc.
Start price
07.10.24
/
50%
€28.20
Target price
07.10.25
€63.74
Performance (%)
-31.91%
Price
27.08.25
€18.50
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Celldex Therapeutics is performing very badly with a performance of -31.91%. This prediction currently runs until 07.10.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 1.087% | 1.087% |
| iShares Core DAX® | -0.959% | -0.959% |
| iShares Nasdaq 100 | 1.557% | 2.255% |
| iShares Nikkei 225® | -0.963% | 3.393% |
| iShares S&P 500 | 1.513% | 2.437% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€41.27
20.08.26
20.08.26
4.35%
27.08.25
27.08.25
